Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INSM |
---|---|---|
09:32 ET | 40055 | 24.95 |
09:34 ET | 1100 | 24.91 |
09:36 ET | 2100 | 24.8999 |
09:38 ET | 100 | 24.79 |
09:39 ET | 1949 | 24.66 |
09:41 ET | 100 | 24.75 |
09:48 ET | 500 | 24.765 |
09:50 ET | 600 | 24.7 |
09:52 ET | 555 | 24.7181 |
09:54 ET | 600 | 24.74 |
09:56 ET | 520 | 24.78 |
09:59 ET | 1214 | 24.7 |
10:01 ET | 1500 | 24.67 |
10:03 ET | 3341 | 24.64 |
10:06 ET | 4461 | 24.63 |
10:08 ET | 1199 | 24.63 |
10:10 ET | 400 | 24.63 |
10:12 ET | 3039 | 24.655 |
10:14 ET | 1900 | 24.61 |
10:15 ET | 5742 | 24.59 |
10:17 ET | 608 | 24.55 |
10:19 ET | 828 | 24.56 |
10:21 ET | 1510 | 24.61 |
10:24 ET | 481 | 24.61 |
10:26 ET | 2263 | 24.55 |
10:28 ET | 700 | 24.545 |
10:30 ET | 400 | 24.54 |
10:32 ET | 1947 | 24.554 |
10:33 ET | 2608 | 24.58 |
10:35 ET | 700 | 24.56 |
10:37 ET | 1266 | 24.54 |
10:39 ET | 2610 | 24.64 |
10:42 ET | 200 | 24.625 |
10:44 ET | 1511 | 24.63 |
10:46 ET | 5285 | 24.64 |
10:48 ET | 1700 | 24.63 |
10:50 ET | 816 | 24.6251 |
10:51 ET | 2150 | 24.605 |
10:53 ET | 1000 | 24.58 |
10:55 ET | 2762 | 24.62 |
10:57 ET | 1359 | 24.63 |
11:02 ET | 800 | 24.66 |
11:04 ET | 1597 | 24.67 |
11:06 ET | 800 | 24.65 |
11:08 ET | 3140 | 24.58 |
11:09 ET | 2428 | 24.63 |
11:13 ET | 400 | 24.64 |
11:15 ET | 1211 | 24.65 |
11:18 ET | 200 | 24.6 |
11:20 ET | 519 | 24.63 |
11:22 ET | 4408 | 24.61 |
11:24 ET | 2360 | 24.62 |
11:26 ET | 1200 | 24.605 |
11:27 ET | 100 | 24.61 |
11:29 ET | 1848 | 24.62 |
11:31 ET | 300 | 24.6 |
11:33 ET | 1214 | 24.58 |
11:36 ET | 5809 | 24.5101 |
11:38 ET | 800 | 24.56 |
11:40 ET | 2050 | 24.52 |
11:42 ET | 4121 | 24.48 |
11:44 ET | 1200 | 24.48 |
11:45 ET | 2311 | 24.48 |
11:47 ET | 2447 | 24.4 |
11:49 ET | 5990 | 24.41 |
11:51 ET | 3303 | 24.53 |
11:54 ET | 1427 | 24.56 |
11:56 ET | 2893 | 24.57 |
11:58 ET | 2394 | 24.56 |
12:00 ET | 1650 | 24.56 |
12:02 ET | 2226 | 24.56 |
12:03 ET | 4138 | 24.515 |
12:05 ET | 700 | 24.52 |
12:07 ET | 2451 | 24.5199 |
12:09 ET | 908 | 24.52 |
12:12 ET | 2066 | 24.605 |
12:14 ET | 1935 | 24.61 |
12:16 ET | 820 | 24.6 |
12:18 ET | 550 | 24.61 |
12:20 ET | 1316 | 24.62 |
12:21 ET | 2182 | 24.59 |
12:23 ET | 4084 | 24.71 |
12:25 ET | 2233 | 24.6708 |
12:27 ET | 2528 | 24.6624 |
12:30 ET | 58070 | 24.7499 |
12:32 ET | 7381 | 24.8 |
12:34 ET | 7596 | 24.845 |
12:36 ET | 400 | 24.87 |
12:38 ET | 3181 | 24.91 |
12:39 ET | 1971 | 24.88 |
12:41 ET | 1000 | 24.87 |
12:43 ET | 433 | 24.8548 |
12:45 ET | 1962 | 24.87 |
12:48 ET | 296 | 24.86 |
12:50 ET | 600 | 24.86 |
12:52 ET | 1122 | 24.9101 |
12:54 ET | 1700 | 24.93 |
12:56 ET | 300 | 24.93 |
12:57 ET | 1691 | 24.94 |
12:59 ET | 530 | 24.935 |
01:01 ET | 4029 | 24.9453 |
01:06 ET | 300 | 24.96 |
01:08 ET | 900 | 24.95 |
01:10 ET | 601 | 24.9699 |
01:12 ET | 4281 | 24.97 |
01:14 ET | 1330 | 24.96 |
01:15 ET | 1600 | 25 |
01:17 ET | 600 | 25.03 |
01:19 ET | 1187 | 25.03 |
01:21 ET | 689 | 25.04 |
01:24 ET | 700 | 25.06 |
01:26 ET | 1100 | 25.06 |
01:28 ET | 6146 | 25.08 |
01:30 ET | 1300 | 25.09 |
01:32 ET | 2812 | 25.065 |
01:33 ET | 450 | 25.01 |
01:35 ET | 1200 | 25.04 |
01:37 ET | 500 | 25.04 |
01:39 ET | 1100 | 25.03 |
01:42 ET | 3358 | 25.03 |
01:44 ET | 10834 | 25.0699 |
01:46 ET | 2630 | 25.08 |
01:48 ET | 11122 | 24.99 |
01:50 ET | 1200 | 25.02 |
01:51 ET | 2986 | 25.08 |
01:53 ET | 8259 | 25.03 |
01:55 ET | 300 | 25.03 |
01:57 ET | 3445 | 25.03 |
02:00 ET | 4593 | 25.01 |
02:02 ET | 4336 | 24.991 |
02:04 ET | 7605 | 24.89 |
02:06 ET | 1810 | 24.89 |
02:08 ET | 2410 | 24.88 |
02:09 ET | 1016 | 24.91 |
02:11 ET | 1826 | 24.87 |
02:13 ET | 4177 | 24.83 |
02:15 ET | 2330 | 24.8 |
02:18 ET | 2990 | 24.83 |
02:20 ET | 3530 | 24.72 |
02:22 ET | 1350 | 24.72 |
02:24 ET | 3928 | 24.75 |
02:26 ET | 7655 | 24.755 |
02:27 ET | 6314 | 24.8 |
02:29 ET | 19039 | 24.72 |
02:31 ET | 3498 | 24.71 |
02:33 ET | 2998 | 24.79 |
02:36 ET | 7783 | 24.76 |
02:38 ET | 2453 | 24.77 |
02:40 ET | 6616 | 24.8 |
02:42 ET | 1400 | 24.82 |
02:44 ET | 3008 | 24.811 |
02:45 ET | 1700 | 24.81 |
02:47 ET | 1100 | 24.82 |
02:49 ET | 1400 | 24.791 |
02:51 ET | 1300 | 24.81 |
02:54 ET | 6089 | 24.791 |
02:56 ET | 3807 | 24.82 |
02:58 ET | 400 | 24.81 |
03:00 ET | 753 | 24.8 |
03:02 ET | 1545 | 24.81 |
03:03 ET | 4710 | 24.82 |
03:05 ET | 3795 | 24.832 |
03:07 ET | 900 | 24.81 |
03:09 ET | 4709 | 24.865 |
03:12 ET | 5257 | 24.9 |
03:14 ET | 2115 | 24.92 |
03:16 ET | 2050 | 24.91 |
03:18 ET | 4971 | 24.9 |
03:20 ET | 8548 | 24.852 |
03:21 ET | 2831 | 24.86 |
03:23 ET | 100 | 24.85 |
03:25 ET | 2283 | 24.89 |
03:27 ET | 6040 | 24.81 |
03:30 ET | 400 | 24.8 |
03:32 ET | 2758 | 24.78 |
03:34 ET | 17530 | 24.78 |
03:36 ET | 14388 | 24.74 |
03:38 ET | 5981 | 24.7 |
03:39 ET | 10377 | 24.71 |
03:41 ET | 6128 | 24.69 |
03:43 ET | 13450 | 24.66 |
03:45 ET | 15935 | 24.68 |
03:48 ET | 5464 | 24.67 |
03:50 ET | 4238 | 24.68 |
03:52 ET | 13004 | 24.695 |
03:54 ET | 16584 | 24.73 |
03:56 ET | 37608 | 24.71 |
03:57 ET | 25017 | 24.745 |
03:59 ET | 288417 | 24.77 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Insmed Inc | 3.7B | -4.7x | --- |
Axsome Therapeutics Inc | 3.6B | -12.0x | --- |
MorphoSys AG | 2.8B | -5.6x | --- |
Denali Therapeutics Inc | 2.9B | -21.2x | --- |
Maravai LifeSciences Holdings Inc | 2.9B | -11.4x | --- |
Arrowhead Pharmaceuticals Inc | 3.1B | -5.8x | --- |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
---|---|
Revenue (TTM) | $315.5M |
Shares Outstanding | 148.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.85 |
EPS | $-5.23 |
Book Value | $-2.24 |
P/E Ratio | -4.7x |
Price/Sales (TTM) | 11.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -224.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.